Last week, AMCP hosted its second IRA workshop, convening stakeholders to help unpack the complexities of the Inflation Reduction Act and discuss what’s on the horizon. In her latest blog, AMCP CEO Susan Cantrell reflects on the takeaways.
On September 14, 2023, the Department of Health and Human Services (HHS) and the Office for Civil Rights issued the proposed rule titled “Discrimination on the Basis of the Disability in Health and Human Service Programs or Activities". AMCP submitted comments in response to the proposed rule on November 13, 2023.
Nearly 3,000 managed care professionals from health plans, PBMs, pharmaceutical manufacturers, and other managed care organizations convened in Orlando from Oct. 16–19 for AMCP Nexus 2023, the industry’s premier fall meeting.
Every year, volunteers play a key role in helping us shape engaging national meetings, and this year was no different. AMCP News & Views celebrates the amazing members and health care leaders who stepped up to the plate to volunteer their time at Nexus 2023.
AMCP will occasionally publish highlights from AMCP and other conferences designed for those in managed care pharmacy. Highlights include summaries of select featured sessions and posters. Meetings published currently include the AMCP Annual 2023, Psych Congress 2023, and the American Psychiatric Association 2023 Annual Meeting.
October 2023 Legislative & Regulatory Briefing: Now Available: “Access, Affordability, and Outcomes: The Value of Managed Care Pharmacy”; AMCP Comments on Maximum Monthly Cap on Cost-Sharing Payments Under Prescription Drug Plan; AMCP Makes Headlines on PDTs, Nexus 2023; BBCIC Awarded $1.4 Million Grant From the FDA; AMCP Comments on Medicaid Program; Misclassification of Drugs, Program Administration, and Program Integrity Updates Under the Medicaid Drug Rebate Program.